@article{d2c801b019424ca987f78224dc238e66,
title = "Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987",
abstract = "The combination of gemcitabine plus cisplatin (GC) is a standard regimen in patients with locally advanced or metastatic urothelial cancer. A phase I/II study suggested that a three-drug regimen that included paclitaxel had greater antitumor activity and might improve survival.",
author = "Joaquim Bellmunt and {von der Maase}, Hans and Mead, {Graham M} and Iwona Skoneczna and {De Santis}, Maria and Gedske Daugaard and Andreas Boehle and Christine Chevreau and Luis Paz-Ares and Laufman, {Leslie R} and Eric Winquist and Derek Raghavan and Sandrine Marreaud and Sandra Collette and Richard Sylvester and {de Wit}, Ronald",
year = "2012",
doi = "10.1200/JCO.2011.38.6979",
language = "English",
volume = "30",
pages = "1107--13",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "10",
}